We are delighted to announce that Quimigen is participation is the Advances in Biosciences Seminar Series, that'll be held in the The Francis Crick Institute, London on December th 10th,2024.
We are eager to announce Clinisciences' particiption in the XII CajalXmas Meeting 2024, that's takng place in the Center for Interdisciplinary Research of Alcalá de Henares (Ci2A) Spain, on the 18th and 19th of December 2024.
Quimigen Group, a European distributor of reagents and equipment for scientific research and medical diagnosis, has acquired Oncomedics, a French biotechnology company specialising in the personalisation of cancer treatments.